Arkolith/Insider Trading/SANA/Form 4

Harr Steve

President & CEO, DirectorSana Biotechnology, Inc. (SANA) · full profile →Form 4 · filed Mar 10, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
2 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 10, 2025Tax withholding(F)13K$2.56$33K7.9M
Mar 7, 2025Option exercise(M)50K—$07.9M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 7, 2025Option exercise(M)50K—$0150K
Mar 6, 2025Grant(A)750K—$0750K
Mar 6, 2025Grant(A)167K—$0167K

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-25-002271) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML